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Cadaveric lung donors have a catecholamine storm ofbrain death, followed by proinflammatory cytokineresponse and subsequent pituitary failure. After thestorm, a drop in circulating catecholamines and vaso-
paresis occur,1 and exogenous catecholamines are often adminis-
tered to support systemic vascular resistance and maintain organ
perfusion before retrieval.
The exogenous administration of catecholamines (EAC) to
organ donors appears to improve outcome after renal and possibly
liver transplantation, but in heart transplantation EAC is associated
with a worse prognosis.2 EAC has been shown to increase alveolar
fluid clearance after brainstem death,3 but the impact on graft
function and recipient outcome after lung transplantation is not
known. We hypothesized that EAC might be beneficial in lung
transplantation.
Patients and Methods
We retrospectively analyzed prospectively collected data from 60
consecutive lung transplant donors and recipients (June 1993 to
September 2003). The PaO2/inspired oxygen fraction (FIO2) ratios
at FIO2 1.0 with 5 mm positive end-expiratory pressure immedi-
ately before retrieval were calculated. Donors were categorized
according to catecholamine use from the time of referral for
donation to surgery. No EAC was defined as the use of dopamine
at less than 2.5 g/(kg · min) and included those patients receiving
vasopressin as a vasoconstrictor. Donors receiving dopamine at 2.5
g/(kg · min) or greater, epinephrine, or norepinephrine during the
retrieval period were categorized as recipients of EAC. We set a
cutoff of less than 2.5 g/(kg · min) dopamine use because many
hemodynamically stable donors receive this dosage per donor
hospital protocol.
All recipient operations were conducted with cardiopulmonary
bypass. In bilateral lung transplants, reperfusion occurred simul-
taneously for both lungs. For recipients, similar demographic data
were collected, together with diagnosis, ischemic time, reperfusion
strategy, and the PaO2/FIO2 ratio at 6 hours postimplantation.
Means and SDs were calculated for data with a normal distri-
bution, and medians were calculated for other data. Comparisons
were made with paired and unpaired t tests, the Mann-Whitney U
test, and the Fisher exact test.
Results
Sixty donors were evaluated, 29 with EAC and 31 without EAC
(Table 1). Donors without EAC were older, but recipients were
similarly aged (EAC 52  10 years, range 19-63 years, no EAC
54  7 years, range 39-63 years, P  .4). There were no differ-
ences in diagnostic category or procedure performed. Traumatic-
cause donors were more likely to require catecholamine (P .03).
The predominant preservation technique in both groups was pul-
monary arterial flush with blood-albumin solution. Controlled
reperfusion (limited pulmonary artery pressure of 20 mm Hg for
15 minutes of initial perfusion) and nitric oxide inhalation at
implantation (10-20 ppm for the first 6 hours) was nonsignificantly
more frequent (P  .12) in the non-EAC group. Ischemic times
were similar (P  .3).
Both EAC and non-EAC groups had a fall in PaO2/FIO2 ratio
between retrieval and 6 postoperative hours (P  .01; Table 2).
This fall was greater in the EAC group (P  .05). The data also
suggest a trend toward higher FIO2 and lower PaO2/FIO2 ratio in this
group. The duration of mechanical ventilation was similar (EAC
median 3 days, non-EAC median 2 days, P  .49). On univariate
analysis, the change from donor to 6-hour recipient PaO2/FIO2 did
not correlate with ischemic time, preservation technique, operation
type, or reperfusion strategy.
Discussion
This study clearly demonstrates that the process of lung retrieval,
transportation, storage, and implantation results in a significant
decline in gas exchange after transplantation. Contrary to our
initial hypothesis, EAC was associated with worse gas exchange
after lung transplantation. This difference was not related to isch-
emic time, preservation technique, or recipient diagnosis.
This finding is of interest, because we anticipated that EAC might
have been protective, as in other noncardiac solid-organ transplanta-
tion. Catecholamines may reduce the impact of ischemia-reperfusion
injury by modulation of leukocyte adhesion mechanisms4 and might
be expected to promote alveolar fluid clearance.5
A number of possible explanations of our findings in this
preliminary study can be proposed. First, it is possible that donors
requiring EAC constitute a group with a more severe initial cate-
cholamine storm, potentially resulting in greater direct pulmonary
injury or proinflammatory cytokine activation. Alternatively, be-
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cause EAC may have been required to support cardiac function,
pulmonary injury may have been exacerbated by elevated left
atrial pressure. These findings require confirmation from larger
studies.
Conclusion
Impairment in early gas exchange is a uniform observation after
lung procurement, preservation, and implantation. EAC in the
donor was associated with worse posttransplantation gas exchange.
Change from donor to 6-hour recipient PaO2/FIO2 may provide a
useful summary assessment of early lung function after implanta-
tion.
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TABLE 1. Donor, recipient, preservation, and reperfusion
details
EAC
(n  29)
No EAC
(n  31)
P
value
Donor age (y, median and range) 33 (11-44) 45 (17-59) .002
Cause of brain death (No.) .03
Intracranial hemorrhage 14 25
Head injury 10 4
Other 5 2
Preservation technique (No.) .9
Papworth flush 20 22
Other flush solution 6 5
Core cooling 3 4
Reperfusion strategy (No.) .12
Uncontrolled reperfusion 21 16
Controlled reperfusion with
nitric oxide
8 15
Ischemic time (min, mean  SD) 294  74 273  69 .3
Recipient age (y, mean  SD) 52  10 54  7 .4
Recipient disease (No.) .9
Emphysema 18 19
Fibrotic disease 7 6
Septic disease 2 2
Other 2 4
Type of transplant (No.)
Single lung 14 14
Bilateral lung 15 17 .999
Duration of ventilation (d, median
and range)
3 (1-140) 2 (1-48) .49
TABLE 2. Comparisons of gas exchange in donor and re-
cipient
EAC
(n  29)
No EAC
(n  31)
P
value
Donor PaO2/FIO2 (FIO2 1.0) 504 74 486 86 .4
Recipient 6 h postimplantation
PaO2 (mm Hg) 103 39 107 21 .59
FIO2 0.47 0.15 0.40 0.11 .07
PaO2/FIO2 ratio 244 111 292 91 .06
Change from donor PaO2/FIO2 272 111 200 137 .05
All data are mean  SD.
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